Literature DB >> 19816624

Adherence to guidelines for surveillance colonoscopy in patients with ulcerative colitis at a Canadian quaternary care hospital.

Dan Kottachchi1, Derek Yung, John K Marshall.   

Abstract

BACKGROUND: Patients with ulcerative colitis (UC) are at high risk of colonic dysplasia. Therefore, surveillance colonoscopy to detect early dysplasia has been endorsed by many professional organizations.
OBJECTIVES: To determine whether gastroenterologists at Hamilton Health Sciences (Hamilton, Ontario) adhere to recommendations for UC surveillance issued by the Canadian Association of Gastroenterology and to retrospectively assess the incidence and type of dysplasia found and the subsequent outcome of patients with dysplasia (ie, colorectal cancer [CRC], colectomy, dysplasia recurrence).
METHODS: A retrospective chart review of all patients with UC undergoing colonoscopy screening at Hamilton Health Sciences from January 1980 to January 2005, was performed. Patients were classified by the extent of colonic disease: limited left-sided colitis (LSC), pancolitis and any disease extent with concurrent primary sclerosing cholangitis.
RESULTS: A total of 141 patients fulfilled eligibility criteria. They underwent 921 endoscopies, including 453 for surveillance, which were performed by 20 endoscopists. Overall, screening was performed on 90% of patients, and surveillance at the appropriate time in 74%. There was a statistically significant increase in the mean number of biopsies per colonoscopy after the guidelines were published (P<0.01 for all categories). Colonic dysplasia was detected in 24 of 141 patients (17.0%), with 17 of 24 (70.8%) found at surveillance. Two patients (8.3%) had CRC successfully treated. The average age of patients with dysplasia was 56.1 years, with a mean disease duration of 10.9 years in LSC versus 11.8 years in pancolitis (P not significant). Colectomy was not recommended for any patient with flat dysplasia. No patients progressed to high-grade dysplasia or CRC. Patients with pancolitis had a higher incidence of neoplasia (21% [18 of 86]) than patients with LSC (12% [6 of 49]; P=0.24). Forty-one patients (29.5%) had at least one hyperplastic or inflammatory polyp.
CONCLUSIONS: For the majority of patients who underwent surveillance colonoscopies, their procedures were performed within the recommended time intervals, and biopsy compliance has improved. Dysplasia tended to arise after approximately 10 years of disease duration and in middle age, with flat dysplasia being rare. Interventions resulted in no dysplasia progressing to CRC, implying successful prevention.

Entities:  

Mesh:

Year:  2009        PMID: 19816624      PMCID: PMC2776550          DOI: 10.1155/2009/691850

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  27 in total

1.  Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease.

Authors:  J A Eaden; J F Mayberry
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

2.  Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: Guidelines on colon cancer screening.

Authors:  Desmond Leddin; Richard Hunt; Malcolm Champion; Alan Cockeram; Nigel Flook; Michael Gould; Young-In Kim; Jonathan Love; David Morgan; Susan Natsheh; Dan Sadowski
Journal:  Can J Gastroenterol       Date:  2004-02       Impact factor: 3.522

3.  Ulcerative colitis and colorectal cancer. A population-based study.

Authors:  A Ekbom; C Helmick; M Zack; H O Adami
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

4.  Increased risk of cancer in ulcerative colitis: a population-based cohort study.

Authors:  P Karlén; R Löfberg; O Broström; C E Leijonmarck; G Hellers; P G Persson
Journal:  Am J Gastroenterol       Date:  1999-04       Impact factor: 10.864

5.  Most dysplasia in ulcerative colitis is visible at colonoscopy.

Authors:  Matthew D Rutter; Brian P Saunders; Kay H Wilkinson; Michael A Kamm; Christopher B Williams; Alastair Forbes
Journal:  Gastrointest Endosc       Date:  2004-09       Impact factor: 9.427

6.  Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis.

Authors:  P M Choi; F W Nugent; D J Schoetz; M L Silverman; R C Haggitt
Journal:  Gastroenterology       Date:  1993-08       Impact factor: 22.682

7.  Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence.

Authors:  Sidney Winawer; Robert Fletcher; Douglas Rex; John Bond; Randall Burt; Joseph Ferrucci; Theodore Ganiats; Theodore Levin; Steven Woolf; David Johnson; Lynne Kirk; Scott Litin; Clifford Simmang
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

8.  Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.

Authors:  W R Connell; J E Lennard-Jones; C B Williams; I C Talbot; A B Price; K H Wilkinson
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

Review 9.  Diagnosis and management of dysplasia in patients with inflammatory bowel diseases.

Authors:  Steven H Itzkowitz; Noam Harpaz
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

10.  Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population.

Authors:  K Hata; T Watanabe; S Kazama; K Suzuki; M Shinozaki; T Yokoyama; K Matsuda; T Muto; H Nagawa
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

View more
  7 in total

1.  Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis.

Authors:  Gauree Gupta Konijeti; Mark G Shrime; Ashwin N Ananthakrishnan; Andrew T Chan
Journal:  Gastrointest Endosc       Date:  2013-11-18       Impact factor: 9.427

Review 2.  Implementing quality measures for inflammatory bowel disease.

Authors:  Shahzad Ahmed; Corey A Siegel; Gil Y Melmed
Journal:  Curr Gastroenterol Rep       Date:  2015-04

3.  Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases.

Authors:  Ashwin N Ananthakrishnan; Andrew Cagan; Tianxi Cai; Vivian S Gainer; Stanley Y Shaw; Susanne Churchill; Elizabeth W Karlson; Shawn N Murphy; Isaac Kohane; Katherine P Liao
Journal:  Clin Gastroenterol Hepatol       Date:  2014-07-17       Impact factor: 11.382

Review 4.  Quality improvement in gastroenterology clinical practice.

Authors:  Rakhi Kheraj; Sumeet K Tewani; Gyanprakash Ketwaroo; Daniel A Leffler
Journal:  Clin Gastroenterol Hepatol       Date:  2012-08-16       Impact factor: 11.382

5.  Myelosuppression monitoring after immunomodulator initiation in veterans with inflammatory bowel disease: a national practice audit.

Authors:  J K Hou; J R Kramer; P Richardson; S Sansgiry; H B El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2012-10-14       Impact factor: 8.171

6.  Automated identification of surveillance colonoscopy in inflammatory bowel disease using natural language processing.

Authors:  Jason K Hou; Mimi Chang; Thien Nguyen; Jennifer R Kramer; Peter Richardson; Shubhada Sansgiry; Leonard W D'Avolio; Hashem B El-Serag
Journal:  Dig Dis Sci       Date:  2012-10-21       Impact factor: 3.199

7.  Patterns and predictors of adherence to colorectal cancer screening recommendations in Alberta's Tomorrow Project participants stratified by risk.

Authors:  Nathan M Solbak; Jian-Yi Xu; Jennifer E Vena; Ala Al Rajabi; Sanaz Vaseghi; Heather K Whelan; S Elizabeth McGregor
Journal:  BMC Public Health       Date:  2018-01-25       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.